These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1913476)

  • 21. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: analysis by Northern blotting and in situ hybridization.
    Morita S; Sato A; Hayakawa H; Ihara H; Urano T; Takada Y; Takada A
    Int J Cancer; 1998 Oct; 78(3):286-92. PubMed ID: 9766559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indirect activation of blood coagulation in colon cancer.
    Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
    Thromb Haemost; 1989 Dec; 62(4):1062-6. PubMed ID: 2694422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasminogen activation in healing human wounds.
    Schäfer BM; Maier K; Eickhoff U; Todd RF; Kramer MD
    Am J Pathol; 1994 Jun; 144(6):1269-80. PubMed ID: 8203466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
    Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased plasma levels of urokinase-type plasminogen activator with endometrial and cervical cancer.
    Koelbl H; Kirchheimer JC; Tatra G; Christ G; Binder BR
    Obstet Gynecol; 1988 Aug; 72(2):252-6. PubMed ID: 3134631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer cell expression of urokinase-type plasminogen activator receptor mRNA in squamous cell carcinomas of the skin.
    Rømer J; Pyke C; Lund LR; Ralfkiaer E; Danø K
    J Invest Dermatol; 2001 Mar; 116(3):353-8. PubMed ID: 11231307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.
    Pyke C; Kristensen P; Ralfkiaer E; Grøndahl-Hansen J; Eriksen J; Blasi F; Danø K
    Am J Pathol; 1991 May; 138(5):1059-67. PubMed ID: 1850957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrin deposition in primary and metastatic human brain tumours.
    Bárdos H; Molnár P; Csécsei G; Adány R
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):536-48. PubMed ID: 8874864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.
    Shoji M; Hancock WW; Abe K; Micko C; Casper KA; Baine RM; Wilcox JN; Danave I; Dillehay DL; Matthews E; Contrino J; Morrissey JH; Gordon S; Edgington TS; Kudryk B; Kreutzer DL; Rickles FR
    Am J Pathol; 1998 Feb; 152(2):399-411. PubMed ID: 9466566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is thrombomodulin useful as a tumor marker of a lung cancer?
    Tamura A; Komatsu H; Hebisawa A; Kurashima A; Mori M; Katayama T
    Lung Cancer; 1996 Sep; 15(2):189-95. PubMed ID: 8882985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.
    Chapman HA; Stone OL; Vavrin Z
    J Clin Invest; 1984 Mar; 73(3):806-15. PubMed ID: 6368589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of factors of coagulation and fibrinolysis in progression of lung cancer].
    Nagayama M; Tachibana A; Hayakawa H; Sato A
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):180-5. PubMed ID: 8390588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological consequences of loss of plasminogen activator gene function in mice.
    Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
    Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical localization of human lung adenocarcinoma-associated antigen with a monoclonal antibody.
    Kato K; Bunai Y; Kuniyasu T; Yoshimi N; Mori H; Saji S; Sakata K
    Jpn J Clin Oncol; 1988 Jun; 18(2):105-12. PubMed ID: 2454334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The macrophage and fibrinolysis.
    Loscalzo J
    Semin Thromb Hemost; 1996; 22(6):503-6. PubMed ID: 9122715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD34-positive stromal cells in primary lung carcinomas.
    Nakayama H; Enzan H; Yamamoto M; Miyazaki E; Hidaka C; Okumichi T; Okumichi A; Kajihara H
    Oncol Rep; 2003; 10(5):1313-6. PubMed ID: 12883699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.